Page: 12 of 30 8 9 10 11 12 13 14 15 16

Dr Gregory Beatty - University of Pennsylvania, USA Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Dr Beatty discusses his research into the use of the CD40 agonist monoclonal antibody CP-870,893 to treat pancreatic cancer. When used in conjuncti...

Prof Gilles Salles - Universite Claude Bernard Lyon, France Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Salles discusses the results he is presenting at ASCO 2010 from the PRIMA study. This trial assessed the efficacy of rituximab as a maintenanc...

Dr Keith Stewart - Mayo Clinic, Arizona, USA Channel: www.ecancer.tv Length: 0 Date: July 16, 2010 Dr Stewart discusses results of Phase I and Phase II trials of carfilzomib, a next generation proteasome inhibitor, which has a different binding ...

Dr Evangelos Terpos - University of Athens, Greece Channel: www.ecancer.tv Length: 0 Date: July 16, 2010 Dr Evangelos Terpos, speaking at EHA 2010, discusses bone disease in multiple myeloma and the targeted therapies for treatment and prevention of s...

Dr Elisabeth Pitterman - Hanusch Hospital, Vienna, Austria Channel: www.ecancer.tv Length: 0 Date: July 15, 2010 Dr Elisabeth Pitterman, an Austrian delegate at ASCO Chicago 2010, gives her views and highlights of the joint ASCO-ASH education session. (In Ger...

Dr Karim Fizazi - Institut Gustave Roussy, France Channel: www.ecancer.tv Length: 0 Date: July 08, 2010 Dr Karim Fizazi discusses his phase III trial which compared the efficacy of denosumab with zoledronic acid in patients with matastatic castration-...

Dr Brigitte Rack, Munich University Hopsital, Germany Channel: www.ecancer.tv Length: 0 Date: July 08, 2010 Data from the SUCCESS trial, presented at ASCO, looked at circulating tumour cells in primary breast cancer.  Dr. Brigitte Rack ta...

Professor Bruce Cheson, Lombardi Comprehensive Cancer Center, Washington DC, USA Channel: www.ecancer.tv Length: 0 Date: July 06, 2010 Data presented at the Joint ASH/ASCO Educational Meeting suggested good results for new frontline treatments for various lymphomas. Prof. Bruce Che...

Prof Gordon McVie, Prof Richard Sullivan, Prof Reinhard Stauder, Prof Mario Boccadoro, Prof Pierre Fenaux Channel: www.ecancer.tv Length: 0 Date: June 30, 2010 Healthcare experts discuss the care of the elderly in haemato-oncology, looking at the current situation across Europe and what is needed to chang...

Professor Chris Twelves - St James’s Hospital, Leeds, UK Channel: www.ecancer.tv Length: 0 Date: June 30, 2010 A new study presented at ASCO has found that eribulin can extend the survival rates of women with locally recurrent or metastatic breast cancer in ...

Dr Thierry Le Chevalier - Gustave-Roussy Institute, Villejuif, France Channel: www.ecancer.tv Length: 0 Date: June 30, 2010 Dr Le Chevalier speaks about the work carried out at the Gustave-Roussy Institute and the difficulties faced when treating lung cancer. In order to...

Prof David Cameron, Dr Christopher M Nutting, Dr Ruth Pettengell, Professor Jacek Jassem Channel: www.ecancer.tv Length: 0 Date: June 30, 2010 Prof David Cameron chairs a round table debate on clinical trial design and comparator arms. The discussion examines issues such as the need to fas...

Prof David Cameron, Prof Patrick Schöffski, Prof Hilary Calvert Channel: www.ecancer.tv Length: 0 Date: June 30, 2010 This roundtable discussion looks at the advantages and disadvantages of overall survival and progression free survival as primary end points of cli...

Prof Jacek Jassem - University of Gdansk, Poland Channel: www.ecancer.tv Length: 0 Date: June 29, 2010 Prof Jassem talks about advances in the treatment of lung cancer and the number of options that are now available to patients. More effective and s...

Professor Ignace Vergote - Catholic University of Leuven, Belgium Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Professor Ignace Vergote speaks about his research into NKTR-102, a new drug for treating women with platinum-resistant/refractory ovarian cancer....

Professor Richard Sullivan, King’s College London, UK Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Prof Richard Sullivan talks about a collaborative initiative to push the issue of cancer and the elderly up the social-political agenda. He suggest...

Prof Gareth Morgan, Institute of Cancer Research, Sutton, UK Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Results of a multiple myeloma study, presented at ASCO, has found that zoledronic acid (Zometa) reduces the incidence of skeletal related events a...

Dr Mathias Rummel - University Hospital, Giessen, Germany Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Although it is known that rituximab (trade name Rituxan) should be used in combination with chemotherapy to treat patients with indolent lymphoma d...

Professor Jesús San-Miguel, University Hospital of Salamanca, Spain Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Prof Jesús San-Miguel, speaking to Prof Gordon McVie, talks about the progression in myeloma survival rates and the contributing factors. ...

Jan Geissler, Director, European Cancer Patient Coalition Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Jan Geissler talks about the issue of ageism in cancer treatment, discussing the reasons why older patients don’t appear to receive as good a trea...

Page: 12 of 30 8 9 10 11 12 13 14 15 16